Zichuan Yu

Nanchang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Identification of the immune-related diagnostic biomarkers between Graves' disease and thyroid carcinoma based on comprehensive bioinformatics analysis and machine learning.

Identification of the immune-related diagnostic biomarkers between Graves' disease and thyroid carcinoma based on comprehensive bioinformatics analysis and machine learning.

Journal: Autoimmunity
Published: February 23, 2026

Deciphering Angiogenic Drivers in Hepatocellular Carcinoma: From Prognostic Signature Construction to Genistein-Mediated Inhibition.

Deciphering Angiogenic Drivers in Hepatocellular Carcinoma: From Prognostic Signature Construction to Genistein-Mediated Inhibition.

Journal: Journal of cellular and molecular medicine
Published: November 19, 2025

SIRPα blockade therapy potentiates immunotherapy by inhibiting PD-L1+ myeloid cells in hepatocellular carcinoma.

SIRPα blockade therapy potentiates immunotherapy by inhibiting PD-L1+ myeloid cells in hepatocellular carcinoma.

Journal: Cell death & disease
Published: March 03, 2025

Downregulated granzyme M expression: implications for the immune system and prognosis of thyroid cancer.

Downregulated granzyme M expression: implications for the immune system and prognosis of thyroid cancer.

Journal: Gene
Published: November 26, 2024

A Molecular Signature of the Ubiquitin-Proteasome System for Forecasting Prognosis in Thyroid Carcinoma Patients.

A Molecular Signature of the Ubiquitin-Proteasome System for Forecasting Prognosis in Thyroid Carcinoma Patients.

Journal: Journal of inflammation research
Published: October 08, 2024

An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer.

An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer.

Journal: Aging
Published: December 05, 2023

Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification.

Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification.

Journal: Aging
Published: November 14, 2023

LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior.

LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior.

Journal: Aging
Published: August 20, 2023

Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity.

Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity.

Journal: Aging
Published: April 03, 2023

Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma.

Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma.

Journal: Aging
Published: January 01, 2023

FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma.

FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma.

Journal: Aging
Published: December 28, 2022

ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m6A modification, and drug susceptibility.

ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m6A modification, and drug susceptibility.

Journal: Aging
Published: September 21, 2022
Showing 1-12 of 14

Last Updated: 09/26/2026